Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Apr;11(4):625–630. doi: 10.1128/aac.11.4.625

Therapeutic Evaluation of Minocycline and Tetracycline for Mixed Anaerobic Infection in Mice

Gale B Hill 1
PMCID: PMC352040  PMID: 856014

Abstract

Minocycline has demonstrated greater in vitro activity against anaerobic bacteria than its parent compound, tetracycline. In vivo therapeutic efficacy of the two drugs was tested against a mixed anaerobic infection in a mouse model. Fusobacterium necrophorum plus F. nucleatum injected intraperitoneally produced progressive intrahepatic and occasional extrahepatic abscesses, which were measured at autopsy. Three treatment regimens were tested, single daily doses of antibiotic being administered by oral gavage: four doses begun at 2 or 24 h after challenge and 14 doses begun 3 weeks after challenge when abscesses were well developed. Autopsy was not performed until several weeks after completion of treatment to assess long-term effects. Based on the number of mice without lesions, the median effective dose (ED50) in milligrams per kilogram per dose for minocycline was significantly lower than that for tetracycline with each regimen tested. With the 2-h (immediate therapy) regimen and the 24-h-delayed therapy regimen, minocycline was 30 and 6 times, respectively, more effective against hepatic abscesses than tetracycline on a weight basis. With each antibiotic, abscesses outside the liver were more resistant to therapy, although again minocycline was more effective. In the treatment of developed abscesses (3-week-delayed regimen), minocycline was effective (ED50 <16 mg/kg), whereas tetracycline was ineffective (ED50 >256 mg/kg). Minocycline has demonstrated greater therapeutic efficacy in vivo than tetracycline in this experimental infection, which is similar, in certain aspects, to human anaerobic infection. These data support further evaluation of the clinical usefulness of minocycline.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow A. W., Patten V., Guze L. B. Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline. Antimicrob Agents Chemother. 1975 Jan;7(1):46–49. doi: 10.1128/aac.7.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Finegold S. M., Bartlett J. G., Chow A. W., Flora D. J., Gorbach S. L., Harder E. J., Tally F. P. Management of anaerobic infections. Ann Intern Med. 1975 Sep;83(3):375–389. doi: 10.7326/0003-4819-83-3-375. [DOI] [PubMed] [Google Scholar]
  3. Gorbach S. L., Bartlett J. G. Anaerobic infections (second of three parts). N Engl J Med. 1974 May 30;290(22):1237–1245. doi: 10.1056/NEJM197405302902207. [DOI] [PubMed] [Google Scholar]
  4. Gorbach S. L., Bartlett J. G. Anaerobic infections (third of three parts). N Engl J Med. 1974 Jun 6;290(23):1289–1294. doi: 10.1056/NEJM197406062902305. [DOI] [PubMed] [Google Scholar]
  5. Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
  6. Hill G. B., Osterhout S., Pratt P. C. Liver abscess production by non-spore-forming anaerobic bacteria in a mouse model. Infect Immun. 1974 Mar;9(3):599–603. doi: 10.1128/iai.9.3.599-603.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kelly R. G., Kanegis L. A. Metabolism and tissue distribution of radioisotopically labelled minocycline. Toxicol Appl Pharmacol. 1967 Jul;11(1):171–183. doi: 10.1016/0041-008x(67)90036-1. [DOI] [PubMed] [Google Scholar]
  8. Kuck N. A. Effects of minocycline and other antibiotics on Fusobacterium necrophorum infections in mice. Antimicrob Agents Chemother. 1975 Apr;7(4):421–425. doi: 10.1128/aac.7.4.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Macdonald H., Kelly R. G., Allen E. S., Noble J. F., Kanegis L. A. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther. 1973 Sep-Oct;14(5):852–861. doi: 10.1002/cpt1973145852. [DOI] [PubMed] [Google Scholar]
  10. Sabbaj J., Sutter V. L., Finegold S. M. Anaerobic pyogenic liver abscess. Ann Intern Med. 1972 Oct;77(4):627–638. doi: 10.7326/0003-4819-77-4-629. [DOI] [PubMed] [Google Scholar]
  11. Sutter V. L., Kwok Y. Y., Finegold S. M. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol. 1972 Feb;23(2):268–275. doi: 10.1128/am.23.2.268-275.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wilkins T. D., Smith L. D. Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice. Antimicrob Agents Chemother. 1974 Jun;5(6):658–662. doi: 10.1128/aac.5.6.658. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES